Originally posted on the NIH website ORIP’s S10 Instrumentation Grant Programs support purchases of state-of-the-art commercially available instruments to enhance research of NIH–funded [...]

During the recent meeting of the European Society of Radiotherapy and Oncology, there was a focus on the treatment of complex skin cancer targets using radiation therapy. Several treatment [...]

All that we are able to accomplish here at Xstrahl is because of our diversely skilled team that takes pride in each area of their work. Every piece of equipment developed by our knowledgeable [...]

ATLANTA (PRWEB) DECEMBER 18, 2020 Xstrahl announced today that Advanced Skin & Laser Center is the first comprehensive dermatology center in the Nashville area to deliver superficial [...]

COVID-19 has created unprecedented challenges across the medical industry, and cancer treatment is no exception. Several articles have already been published that examine the impact the pandemic [...]

Today’s radiation research is full of complexity and investigators have very diverse interests. Figuring out how to support novel research approaches is not a trivial task, especially when [...]

Xstrahl’s success is made possible by a team with varied skills and responsibilities. Throughout the research, development and production, our purchasing team works hard to ensure we have the [...]

As we mark our silver anniversary, it’s a time to reflect on the amazing journey we shared with you to envision, develop, and refine solutions that deliver a meaningful impact to patient care [...]

Dr. Shaffer will help support the use of radiation therapy for skin cancer and benign disease. ATLANTA, GA  – September 24, 2020 As skin cancer incidence continues to rise, we want to we [...]

ATLANTA, GA –Xstrahl, a medical technology company that designs clinical and research systems to help eradicate cancer, has named its new chief operating officer, Mike Ingebrand. Ingebrand brings [...]

Publication: Synergistic Anticancer Activity of N-Hydroxy-7-(2-Naphthylthio) Heptanomide, Sorafenib, and Radiation Therapy in Patient-Derived Anaplastic Thyroid Cancer Models Authors: Yun, Hyeok Jun, Kim, Hee Jun Kim, Jungmin Kim, Sang Yong Chang, Hang-Seok Park, Cheong Soo Chang, Ho-Jin Park, Ki Cheong International Journal of Molecular Sciences Abstract: Anaplastic thyroid cancer (ATC) is an undifferentiated and advanced form […]

Study: Radiotherapy Delivered before CDK4/6 Inhibitors Mediates Superior Therapeutic Effects in ER+ Breast Cancer Authors: Petroni, Giulia Buqué, Aitziber Yamazaki, Takahiro Bloy, Norma Di Liberto, Maurizio Chen-iang, Selina Formenti, Silvia C. Galluzzi, Lorenzo Purpose: Recent preclinical data suggest that cyclin-dependent kinase 4/6 (CDK4/6) inhibition may be harnessed to sensitize estrogen receptor–positive (ER+) breast cancer to radiotherapy. […]

Publication: Microspheres Encapsulating Immunotherapy Agents Target the Tumor-Draining Lymph Node in Pancreatic Ductal Adenocarcinoma, 04 Jun 2020 Xstrahl System Utilized: SARRP Authors: Booyeon J. Han,Joseph D. Murphy,Shuyang Qin,Jian Ye,Taylor P. Uccello,Jesse Garrett-Larsen,Brian A. Belt,Peter A. Prieto,Nejat K. Egilmez,Edith M. Lord,David C. Linehan,Bradley N. Mills &Scott A. Gerber Introduction The tumor-draining lymph node (TDLN) plays a […]

Objectives Researchers in this study focused on inhibition of TGFB using small molecule inhibitor SM16. Methods The SARRP was used to treat orthotopic pancreatic tumors. They used CT contrast agent, lipuodol, to precisely target the tumor within the soft tissue and deliver radiation using an arc to minimize the damage to normal tissue but deliver […]

Nasal function and cosmesis are important considerations in the quality of life for nasal ala skin cancer patients. Surgery involves tissue loss, which is likely to lead to impaired function and undesired cosmetic results. Superficial radiotherapy can be an effective alternative without these negative side effects, if administered in proper doses. The case studies featured […]

Over his career, Dr. Steven Davis, medical director of The Dermatology & Laser Center of San Antonio has performed over 25,000 skin cancer operations. While surgery is still the primary treatment, it’s not always the best option for the patient, especially people on blood thinners, with diabetes, or cancers on certain parts of the skin. […]

Xstrahl’s new mouse immobilization suite gives you the flexibility you need for your experiments. With over 85% of image guided irradiation publications utilizing SARRP, Xstrahl has always brought research success and flexibility. Mirroring clinical treatments is part of the SARRP DNA and just like in the clinic, set-up is a key part of dose optimization. […]

As we navigate this season of social distancing, we are doing what we can to be available to our network. Part of this includes making more online resources available, especially in light of the many cancelled and postponed events. Even as parts of the industry are paused during this time, we hope to continue expanding […]

For a subset of cancers, the exciting world of ion beam, proton beam and FLASH radiotherapy have presented new opportunities to deliver high doses of ionizing radiation to tumors, with the potential to increasingly spare normal tissue. As these therapies move into more routine clinical practice, it is critical to optimize and validate current treatment […]

With the rates of skin cancers ever increasing, especially in places with high sun prevalence, treatment of these conditions can cause not only a demand on resources, but there is a lack of unified response and the best way to treat. This is why Prof. Gerald Fogarty of GenesisCare in Australia has used the Xstrahl […]